A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Principal Investigator

Dr Simon Rinaldi

Contact us

Email: dendron@ouh.nhs.uk

IRAS number

1011563